Dow Jones 30 Stocks SEC Filings — February 26, 2026

27-02-2026

On February 26, 2026, the Compensation Committee of Iridium Communications Inc. approved the Annual Performance Bonus Plan, making eligible employees including CEO, CFO, and other NEOs eligible for cash or RSU bonuses up to 200% of target based on corporate and individual performance goals for periods starting January 1, 2026. The Committee also adopted the Executive Severance Plan, providing non-CIC severance of 18 months base salary (CEO) or 12 months (other NEOs) plus prorated bonus and COBRA, with enhanced CIC benefits including 2X (CEO) or 1.5X (others) of base plus target bonus and full equity vesting acceleration. These plans are subject to recoupment under the Company's Incentive Compensation Recoupment Policy and will be filed as exhibits to the Q1 2026 10-Q.

• ·Non-CIC severance includes prorated annual target bonus and COBRA premiums for up to 12 months.
• ·CIC severance paid in lump sum with full acceleration of outstanding equity awards.
• ·Plans require execution of waiver/release and compliance with restrictive covenants.

27-02-2026

AXIS Capital Holdings reported full-year 2025 gross premiums written (GPW) of $9.6 billion, up 7% YoY from $9.0 billion, with Insurance segment growing 9% to $7.2 billion while Reinsurance increased modestly 3% to $2.4 billion. The company delivered a strong combined ratio of 89.8%, record underwriting income of $597 million in Insurance, and diluted book value per share of $77.20 (up 18.3% over past 12 months), alongside over $1 billion in capital returns to shareholders. However, growth was cautious in lines like Cyber Insurance, Liability Reinsurance, and Motor Reinsurance, with portfolio reshaping in Public D&O, Primary Liability, and Cyber.

• ·Average quarterly loss ratio of 58.9% since Q1 2024, with lower volatility than peers.
• ·Investment portfolio: 78% fixed maturities (4.6% book yield), average duration 3.1 years, 19% allocation to risk assets.
• ·Teams added: NA Environmental (Jan 2024), US Construction (Jan 2024), Ocean Marine (Jun 2024), Life Sciences (Sep 2024).
• ·G&A ratio improved with GPW up 15% since YE2023 while G&A dollars up only 3%.
• ·A.M. Best and S&P financial strength ratings: A+.

27-02-2026

Apple Hospitality REIT (APLE) reported FY 2025 comparable hotels revenue of $1.4B, down 1.1% YoY, with RevPAR declining 1.6% to $117.95, Occupancy down 1.6% to 74.1%, and Adjusted Hotel EBITDA margin contracting 190 bps to 34.3% amid softer demand. Q4 2025 showed steeper declines with RevPAR down 2.6% YoY to $106.90 and EBITDA down 8.4%, though the company repurchased 4.6M shares for $58.3M, maintained a strong balance sheet with $1.5B net debt (35% to total cap), and achieved TSR outperformance of +20.1 ppts vs. MSCI US REIT Index over 2022-2024. Preliminary January 2026 RevPAR declined ~1.5% YoY, but fundamentals remain solid with 59% of hotels facing no new supply nearby.

• ·Portfolio includes 217 hotels across 37 states and 84 markets, 99% rooms-focused with average effective age of 6 years and 4.3 average Tripadvisor rating.
• ·Acquired 6 hotels in 2023, 2 in 2024, 2 in 2025 (3 under contract); sold 6 in 2024 and 7 in 2025.
• ·64% of outstanding debt effectively fixed; $587M availability under revolving credit facility.
• ·59% of hotels have no new supply under construction within 5-mile radius.
• ·Annualized distribution $0.96 per share; average trading volume TTM 1/31/2026: 2.9M shares/day.

27-02-2026

Algorhythm Holdings, Inc. entered into an Amended and Restated Employment Agreement with Gary Atkinson as Chief Executive Officer, effective February 23, 2026, for an initial three-year term automatically renewable annually unless 90 days' notice is given. Compensation includes a $360K annual base salary, eligibility for up to 50% ($180K) annual bonus (half guaranteed if employed full year, half tied to capital raise and $10M revenue target for FY2026), and a stock option for approximately 5% of fully diluted common shares vesting quarterly over four years. Additional terms include a change-in-control bonus of up to $540K, standard benefits, and a requirement to spend an average of two days per week in the Fort Lauderdale office.

• ·Stock option exercise price equals closing price of common stock on Nasdaq on Effective Date (February 23, 2026).
• ·Agreement supersedes conflicting terms in 2022 Equity Incentive Plan or stock option grant notice.
• ·Executive permitted to maintain prior consulting arrangement with Stingray Music USA, Inc. approved by Board.
• ·Termination requires 30 days' advance written notice unless for Cause.
• ·Company to register shares underlying stock option via amendment to Form S-8 (File No. 333-268106) or new filing by first anniversary of Effective Date.

27-02-2026

Western New England Bancorp, Inc. announced on February 24, 2026, that Paul Picknelly, a member of its Board of Directors, will retire effective May 14, 2026, immediately following the 2026 Annual Meeting of Stockholders. Mr. Picknelly's decision was not due to any disagreement with the company's operations, policies, or practices. No other changes or financial impacts were disclosed.

27-02-2026

Carnival Corporation and Carnival plc propose DLC Unification and Redomiciliation transactions to unify their dual-listed structure under Carnival Corporation Ltd. (redomiciled from Panama to Bermuda) with a single NYSE listing under ticker CCL, eliminating the LSE listing and ADS program. Shareholder meetings, including a Carnival plc Court Meeting and General Meetings for both companies, are set for April 17, 2026, at Carnival Place in Miami, with completion anticipated before the end of Q2 2026 if approved. The Boards unanimously recommend approval, citing benefits such as a single global share price, improved liquidity, reduced administrative costs, and simplified corporate actions; no material risks or downsides are highlighted in the filing.

• ·Request incorporation documents by April 10, 2026, via Company Secretary at (305) 599-2600, ext. 18019.
• ·Carnival plc Court Meeting at 8:30 a.m. EDT, followed by General Meetings, at 3655 N.W. 87th Avenue, Miami, FL 33178; live video broadcast at Carnival House, Southampton, UK, 1:30 p.m. BST.
• ·Conditions include court sanction, shareholder approvals, and regulatory clearances.

27-02-2026

On February 26, 2026, Dipanjan Deb resigned as a member of the Board of Directors of GoodRx Holdings, Inc., effective immediately. Mr. Deb indicated that his decision was not due to any disagreement with the Company on matters relating to its operations, policies, or practices. The resignation was reported in an 8-K filing dated February 27, 2026.

27-02-2026

InfuSystem Holdings, Inc. (INFU) filed a Form 8-K on February 27, 2026, under Item 7.01 Regulation FD Disclosure, furnishing an Investor Presentation dated February 27, 2026, attached as Exhibit 99.1. The disclosure notes that the information is not deemed 'filed' under Section 18 of the Exchange Act or incorporated by reference into other filings. The filing was signed by Barry Steele, Chief Financial Officer.

27-02-2026

Verde Resources, Inc. filed a Form 8-K on February 27, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely related to a shareholder meeting. No specific matters, voting results, outcomes, or any quantitative data such as vote percentages, share counts, or financial implications are disclosed in the provided filing information. This appears to be a mandatory, single-item informational disclosure with no evident positive or negative metrics.

27-02-2026

BrightSpring Health Services, Inc. filed an 8-K on February 27, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results with attached exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details.

• ·Accession Number: 0001193125-26-078998
• ·File Size: 1 MB

27-02-2026

Datavault AI Inc. filed an 8-K on February 27, 2026 (AccNo: 0001104659-26-020936), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, guidance changes, or operational details were disclosed. This represents a material negative development with no mentioned positives or offsets.

27-02-2026

Limitless X Holdings Inc. filed a Form 8-K on February 27, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific details such as transaction value, parties, terms, financial metrics, or impacts are disclosed.

27-02-2026

Ultra Clean Holdings, Inc. filed a Form 8-K on February 27, 2026, reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, events, financial impacts, or quantitative metrics are disclosed. This is a multi-item filing with no period-over-period comparisons, guidance, or named entities beyond the filer provided.

27-02-2026

Ginkgo Bioworks Holdings, Inc. filed an 8-K on 2026-02-27 disclosing entry into a Material Definitive Agreement under Item 1.01. The filing also reports Financial Statements and Exhibits under Item 9.01. No specific details on the agreement terms, transaction value, parties involved, financial impacts, or other metrics are disclosed.

27-02-2026

Bain Capital Specialty Finance, Inc. filed an 8-K on February 27, 2026, disclosing information under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, transaction details, or guidance are provided in the filing summary. This appears to be a multi-item voluntary or mandatory earnings-related disclosure, but quantitative impacts are NOT_DISCLOSED.

27-02-2026

Goldman Sachs BDC, Inc. filed an 8-K on February 27, 2026 (AccNo: 0001193125-26-078362), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are NOT_DISCLOSED. No positive or negative metrics, scheduled events, or transactions detailed in the provided filing information.

27-02-2026

FrontView REIT, Inc. filed a Form 8-K on February 27, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction values, share counts, or financial metrics disclosed in the provided information. No positive or negative performance metrics are mentioned.

27-02-2026

VSE Corp filed an 8-K on February 27, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the financial statements and exhibits are provided in the filing summary. No quantitative metrics, transactions, or forward-looking information are disclosed.

27-02-2026

Anteris Technologies Global Corp. filed an 8-K on February 27, 2026 (AccNo: 0001140361-26-007003), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item voluntary disclosure of financial results. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information.

27-02-2026

Xeris Biopharma Holdings, Inc. filed an 8-K on 2026-02-27 reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material nonpublic information and attached exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing metadata.

27-02-2026

UWM Holdings Corp filed an 8-K on February 27, 2026 (AccNo: 0001783398-26-000018, size 3 MB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosed information, financial metrics, transactions, or exhibits provided. No quantitative data, period-over-period comparisons, or directional metrics are mentioned.

27-02-2026

Delek US Holdings, Inc. filed an 8-K on 2026-02-27 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item voluntary disclosure pertains to financial results. No quantitative metrics, period-over-period comparisons, guidance, or other specific financial details are disclosed.

27-02-2026

Via Transportation, Inc. filed a Form 8-K on 2026-02-27 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or quantitative metrics were disclosed in the provided filing information. Sector was not specified.

27-02-2026

NIQ Global Intelligence plc filed a Form 8-K on 2026-02-27 under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are disclosed in the filing summary. This is a standard voluntary earnings-related disclosure without detailed financial data provided.

27-02-2026

Nuveen AMT-Free Municipal Value Fund filed a Form 8-K on February 27, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the nature of the other events, financial metrics, transactions, or impacts are disclosed in the provided filing information. This appears to be a single-item, voluntary disclosure with no quantitative data available.

27-02-2026

Accelerant Holdings filed an 8-K on 2026-02-27 disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing details. This is a multi-item filing typical for earnings releases under Regulation FD.

27-02-2026

Nuveen Municipal Value Fund Inc filed a Form 8-K on February 27, 2026, under Item 8.01 Other Events. No specific details regarding the core event, transaction, financial metrics, positive or negative changes, or other quantitative data are disclosed in the filing summary provided. This appears to be a single-item voluntary or mandatory disclosure of a material event not covered by other Items, but content is limited.

27-02-2026

Zoomcar Holdings, Inc. filed a Form 8-K on February 27, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the content of the Regulation FD disclosure or the nature of the exhibits provided. No financial metrics, transactions, or performance data are disclosed in the filing summary.

27-02-2026

Sunstone Hotel Investors, Inc. filed an 8-K on February 27, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

27-02-2026

ALX Oncology Holdings Inc filed an 8-K on February 27, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative details were provided in the filing summary. This is an informational earnings-related disclosure with no directional financial impacts detailed.

27-02-2026

Globalstar, Inc. filed an 8-K on February 27, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance changes were disclosed in the provided filing information. No positive, negative, or flat metrics were mentioned.

27-02-2026

GLOBAL PARTNERS LP filed an 8-K on February 27, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or period-over-period comparisons are NOT_DISCLOSED in the provided filing details. No positive or negative metrics are explicitly stated.

27-02-2026

KORE Group Holdings, Inc. filed an 8-K on February 27, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, events, transaction value, financial metrics, or impacts are disclosed in the provided filing summary. All quantitative data, parties involved, and outcomes remain NOT_DISCLOSED.

27-02-2026

SIRIUS XM HOLDINGS INC. filed an 8-K on 2026-02-27 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. Filing size is 239 KB with AccNo: 0001104659-26-021044.

27-02-2026

Avidity Biosciences, Inc. filed an 8-K on February 27, 2026, disclosing the termination of a material definitive agreement (Item 1.02), completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures/elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). These items collectively indicate a completed significant corporate transaction involving change of control and delisting, with no financial metrics, deal values, or performance comparisons provided. Item 9.01 references financial statements and exhibits, but specifics are NOT_DISCLOSED.

27-02-2026

Acrivon Therapeutics, Inc. filed an 8-K on 2026-02-27 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the content of the Regulation FD disclosure or the nature of the exhibits are disclosed in the filing summary. This appears to be a multi-item informational filing with no quantified financial metrics or events provided.

27-02-2026

Envoy Medical, Inc. filed an 8-K on 2026-02-27 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. Item 8.01 reports other events, and Item 9.01 includes financial statements and exhibits. No financial metrics, transaction values, or period-over-period comparisons are disclosed.

• ·Multi-item 8-K filing (Items 3.01, 8.01, 9.01)
• ·Filed on 2026-02-27 with AccNo: 0001213900-26-021116

27-02-2026

International Endeavors Corp filed an 8-K on 2026-02-27 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure, financial statements, or exhibits are provided. No quantitative metrics, events, or impacts are disclosed.

27-02-2026

Ohio Valley Banc Corp filed an 8-K on February 27, 2026 (AccNo: 0000894671-26-000021, Size: 149 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Specific details including the key position affected, individuals involved, appointment or resignation status, reasons for change, and any governance or financial impacts are NOT_DISCLOSED. No quantitative metrics, scheduled events, or other financial data are mentioned in the provided filing information.

27-02-2026

Alaska Silver Corp. filed a Form 8-K on February 27, 2026 (AccNo: 0001062993-26-001190, Size: 246 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material non-public information with attached exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing summary.

• ·AccNo: 0001062993-26-001190
• ·File Size: 246 KB

27-02-2026

Golkor Inc. filed an 8-K on February 27, 2026, disclosing changes in its certifying accountant under Item 4.01. Item 9.01 reports financial statements and exhibits. No additional details on the nature of the change, reasons, new auditor, financial impacts, or quantitative metrics are provided.

27-02-2026

BancFirst Corp (/OK/) filed an 8-K on 2026-02-27 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. Specific details including the key position affected, whether it is an appointment or resignation, internal/external status, reason, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

27-02-2026

Presurance Holdings, Inc. closed its Rights Offering on February 27, 2026, issuing 4,284,640 shares of common stock upon exercise of subscription rights at $1.00 per share and an additional 9,715,360 shares to Clarkston Companies, Inc. under the backstop commitment. The company received $14M in gross proceeds, which are being used to redeem its Series B Preferred Stock including all accrued dividends, and for general corporate purposes. Unexercised rights expired on February 24, 2026, with no negative impacts reported.

• ·Backstop Agreement dated February 3, 2026
• ·Previous 8-K filed January 28, 2026
• ·S-1 registration (File No. 333-292735) effective February 6, 2026
• ·Subscription deadline: 5:00 p.m. ET on February 24, 2026

27-02-2026

AIxC launched Season 2 of its AIxC Hub platform, introducing updated engagement mechanics, Tenki-based features, and ecosystem expansion, with details on playbooks and rewards to be released next week. The company's official X account grew to 53,417 followers, with engagement rates up 94% and total impressions approaching 600,000 over recent weeks. However, AIxC announced it will discontinue BesTrade AI Agent and Digital Asset AI Management modules to focus resources on Real-World Asset (RWA) and Embodied AI (EAI) strategies, including intelligent electric vehicles and AI robotics.

• ·Press release dated February 23, 2026
• ·SEC 8-K filing dated February 27, 2026
• ·Season 2 playbooks, ecosystem rewards, and participation guidelines to be released next week

27-02-2026

Texas Capital Bancshares, Inc. completed a public offering of $400M aggregate principal amount of 5.301% Fixed-to-Floating Rate Senior Notes due February 27, 2032, receiving $398.4M in proceeds before offering expenses. The company intends to use the net proceeds for general corporate purposes, which may include funding the redemption of its 4.000% Subordinated Notes due 2031. The notes bear a fixed interest rate of 5.301% payable semi-annually until February 27, 2031, then transition to a floating rate based on Compounded SOFR plus 1.94% payable quarterly.

• ·Underwriting agreement dated February 24, 2026, with Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and TCBI Securities, Inc. as representatives.
• ·Indenture dated February 27, 2026, with U.S. Bank Trust Company, National Association as trustee.
• ·Offering pursuant to Registration Statement No. 333-277061 filed February 14, 2024, and Prospectus Supplement dated February 24, 2026.
• ·Date of earliest event reported: February 24, 2026; Filing date: February 27, 2026.

27-02-2026

Aviat Networks, Inc. entered into Amendment No. 2 to its Amended and Restated Tax Benefit Preservation Plan with Computershare Inc. on February 27, 2026, extending the plan's final expiration date to March 3, 2029, subject to stockholder ratification at the 2026 annual meeting. The amendment protects the company's Tax Benefits, including net operating losses, which the Board views as valuable assets. If not approved, the plan will terminate upon certification of the voting results.

• ·Original Plan dated August 27, 2020; previously amended February 28, 2023
• ·Filing incorporates Exhibit 4.1: Amendment No. 2

27-02-2026

Fold Holdings, Inc. (NASDAQ: FLD) announced the extinguishment of $66.3 million in convertible note obligations through strategic capital transactions, simplifying its capital structure by eliminating all convertible notes and their restrictive covenants. The company released 521 bitcoin from collateral and reduced potential share dilution by an estimated 8.0 to 10.0 million shares. This positions Fold for growth, including the launch of the Fold Credit Card and expansion into enterprise services.

• ·Transactions restore operational and financing flexibility by removing consent requirements and execution friction from prior notes.
• ·Bitcoin treasury can now support operational expenses, credit card warehouse/reserve requirements, or future financing.

27-02-2026

Northpointe Bancshares, Inc. (NYSE: NPB) announced the appointment of Rodney E. Hood, former Acting Comptroller of the Currency and Chairman of the National Credit Union Administration (NCUA), to the Board of Directors of the Company and its subsidiary Northpointe Bank, effective February 27, 2026. Hood brings nearly three decades of financial services leadership, including roles at the FDIC, FSOC, and FFIEC, to support strategic growth, governance, and risk management. Chairman and CEO Chuck Williams highlighted Hood's expertise in innovation and community value, aligning with the company's focus as a leading mortgage warehouse financing provider.

• ·Headquartered in Grand Rapids, Michigan.
• ·Contacts: Kevin Comps (616-974-8491), Brad Howes (616-726-2585).

27-02-2026

IMAC Holdings, Inc. entered into a secured promissory note on February 26, 2026, with a principal amount of $175,000 issued for a purchase price of $125,000, representing a steep 28.6% discount indicative of distressed financing. The note matures upon written demand by the lender and includes standard events of default such as bankruptcy, with no prepayment penalties. No other financial metrics or performance comparisons were disclosed.

• ·Note is secured and includes customary representations, warranties, covenants, and events of default.
• ·Maturity date: upon holder's written demand.

27-02-2026

Avis Budget Group, Inc. shareholders are notified of proposed voluntary dismissals, subject to court approval, of two shareholder derivative actions filed in 2025 alleging breaches of fiduciary duties and misleading statements related to the company's February 2025 announcement of accelerated fleet rotation and a non-cash impairment for Q4 2024. The actions, Jones v. Pahwa (filed June 6, 2025) and Dua v. Ferraro (filed September 9, 2025), seek unspecified damages and governance changes but are set to be dismissed without prejudice unless another shareholder intervenes by April 13, 2026.

• ·Court ordered notice on November 24, 2025.
• ·Case numbers: Jones v. Pahwa, No. 2:25-cv-07934-MEF-CF; Dua v. Ferraro, No. 2:25-cv-15382-MEF-CF.
• ·Intervention motions due by April 13, 2026, to Clerk of U.S. District Court for the District of New Jersey, 50 Walnut Street, Room 4015, Newark, NJ 07101.
• ·Complaints available at specified URLs.

27-02-2026

Grid Dynamics Holdings, Inc. (GDYN) adopted Amended and Restated By-Laws effective February 26, 2026, as disclosed in an 8-K filing on February 27, 2026 under Items 5.03 and 9.01. The by-laws address standard governance provisions including stockholder meetings (with detailed advance notice requirements for proposals and nominations), board structure, officer roles, indemnification, amendments, exclusive forum provisions, and electronic notices. No financial metrics, changes, or impacts are mentioned.

• ·By-laws effective February 26, 2026
• ·Stockholder notice deadlines: 90-120 days prior to annual meeting anniversary (Pacific Time)
• ·Special meetings callable by Chairperson or majority Board resolution
• ·Advance notice includes detailed disclosures on ownership, derivatives, agreements, and interests exceeding $100,000 in competitors

27-02-2026

Pathfinder Bancorp, Inc. revised its Q4 2025 net loss to $5.6M or $(0.88) per diluted share from the previously reported $7.0M or $(1.11) per share, due to an additional $1.5M non-cash income tax benefit, increasing the Q4 tax benefit to $3.0M. For the full year 2025, the net loss improved to $1.9M or $(0.31) per diluted share from $3.4M or $(0.54) per share, with the annual tax benefit revised to $2.2M. Despite these improvements, the company continues to report net losses for both the quarter and the year.

• ·The $1.5M income tax adjustment is non-cash and reflects updated deferred tax asset analysis as of December 31, 2025.
• ·Corrected financials will be in forthcoming Form 10-K.
• ·Original earnings press release issued January 29, 2026.

27-02-2026

FirstSun Capital Bancorp held a special shareholder meeting on February 27, 2026, where stockholders overwhelmingly approved three key proposals related to its merger with First Foundation Inc., including adoption of the merger agreement dated October 27, 2025, an increase in authorized common stock shares, and creation of a new class of non-voting common stock. Proposal 1 (merger approval) passed with 24,390,817 votes for, 21,071 against, 98,685 abstentions, and 485,766 broker non-votes. All proposals received strong support with no significant opposition.

• ·Definitive joint proxy statement/prospectus filed January 15, 2026, supplemented February 6, 2026.
• ·Proposal 4 (adjournment) withdrawn as not needed due to quorum and approvals.
• ·Merger agreement dated October 27, 2025.

27-02-2026

On February 25, 2026, Visa Inc. deposited $125 million into its U.S. litigation escrow account under the U.S. retrospective responsibility plan, triggering downward adjustments to class B-1 and B-2 common stock conversion rates effective February 26, 2026. This reduced the as-converted class B-1 share count by 7,880 (from 7,490,714 to 7,482,834) and class B-2 by 392,202 (from 181,804,989 to 181,412,787), with effects equivalent to repurchasing class A common stock. No declines or flat metrics reported; the action is EPS accretive.

• ·Class B-1 conversion rate adjusted from 1.5491 to 1.5475
• ·Class B-2 conversion rate adjusted from 1.5108 to 1.5075
• ·Adjustments based on volume-weighted average price on February 25, 2026, per certificate of incorporation

27-02-2026

Callaway Golf Company reported recast continuing operations results excluding Topgolf and Jack Wolfskin divestitures, with total net sales declining 1.6% YoY to $629.6M in Q1 2025 and 2.3% to $600.4M in Q2, for H1 down 1.9% to $1,230.0M, driven by declines across categories including Golf Balls (-4.5% Q2), Apparel (-6.5% Q2), and Gear (-5.0% Q2), while Apparel, Gear and Other segment sales fell 2.1% in Q1 and 5.8% in Q2. However, Golf Equipment operating income rose 23.8% to $101.8M in Q1 and 11.5% to $178.0M in H1, boosting total operating income 30.8% in Q1 and 7.2% in H1 despite a 14.3% Q2 decline to $74.3M. Gross margins improved slightly to 45.0% in Q1 from 43.5% prior.

• ·Q1 2025 gross margin 45.0% vs 43.5% prior (GAAP), U.S. net sales down 1.5% YoY, Europe up 1.7%.
• ·Q2 2025 Europe net sales up 21.4% YoY to $64.6M, Rest of World flat at $42.8M.
• ·Non-GAAP diluted EPS from continuing ops Q1 2025: $0.30 vs $0.28 prior.
• ·Jack Wolfskin sale closed May 31, 2025; Topgolf 60% sale closed Jan 1, 2026 with 40% retained.

27-02-2026

Carnival Corporation and Carnival plc propose a DLC Unification and Redomiciliation, making Carnival plc a wholly-owned subsidiary of Carnival Corporation (redomiciling from Panama to Bermuda as Carnival Corporation Ltd., ticker CCL on NYSE), eliminating dual listings on NYSE and LSE, and terminating the ADS program. Shareholder meetings, including a UK Court Meeting, are set for April 17, 2026, in Miami (with live video in Southampton), with document requests due by April 10, 2026, and completion anticipated before end of Q2 2026. Boards unanimously recommend approval citing benefits like unified share pricing, enhanced liquidity, index weighting, and reduced administrative/regulatory costs; no material risks or declines highlighted.

• ·Meetings at Carnival Place, 3655 N.W. 87th Avenue, Miami, FL 33178-2428, starting 8:30 a.m. EDT; live video at Carnival House, 100 Harbour Parade, Southampton SO15 1ST, UK, 1:30 p.m. BST.
• ·Contact for documents: ATTENTION: COMPANY SECRETARY, TELEPHONE: (305) 599-2600, EXT. 18019.

27-02-2026

Advanced Drainage Systems, Inc. entered into a Fourth Amendment to its Credit Agreement on February 27, 2026, refinancing in full its existing term loans with new 2026 Refinancing Term Loans equal to the outstanding principal and replacing existing revolving commitments with new 2026 Refinancing Revolving Commitments plus incremental commitments to achieve a total revolving facility of $750M. The amendment also includes $192M in new 2026 Incremental Term Loans and replaces Barclays Bank PLC with PNC Bank, National Association as administrative agent. No performance declines noted, but the transactions increase overall debt capacity.

• ·Refinancing matches aggregate principal of existing term loans and revolving commitments outstanding prior to amendment.
• ·Bank of America, N.A. designated as Term Administrative Agent.
• ·PNC Capital Markets LLC, Bank of America, N.A., and others act as joint lead arrangers and bookrunners.

27-02-2026

Bolt Projects Holdings, Inc. disclosed that its independent registered public accounting firm, Elliott Davis, PLLC, resigned effective February 27, 2026, after providing formal notice on February 25, 2026. There were no disagreements on accounting principles, financial disclosures, or auditing procedures, but Elliott Davis' prior audit reports on the 2023 and 2024 financial statements included a going concern qualification and the Company had disclosed material weaknesses in internal controls in its Form 10-K filed March 18, 2025. Elliott Davis furnished a letter to the SEC concurring with the Company's disclosures.

• ·Elliott Davis audited consolidated financial statements as of December 31, 2024 and 2023.
• ·Company is an emerging growth company under Rule 405 and Rule 12b-2.
• ·Securities trade on OTC Pink: Common stock (BSLK), Warrants (BSLKW).
• ·No reportable events under Item 304(a)(1)(v) of Regulation S-K except material weaknesses in 2024 Form 10-K.

27-02-2026

On February 26, 2026, Claire D’Oyly-Hughes Johnson resigned from the Board of Directors of Aurora Innovation, Inc., effective February 27, 2026, with no disagreements on operations, policies, or practices. Effective the same date, David Wehner, age 56 and Chief Strategy Officer at Meta Platforms, Inc. (formerly Facebook, Inc.), was appointed as a new director with a term expiring at the 2027 Annual Meeting of Stockholders. Mr. Wehner, with prior experience as CFO of Meta Platforms and Zynga Inc., is eligible for $60,000 in annual cash compensation plus equity awards under the Director Compensation Policy.

• ·David Wehner holds an M.S. in applied physics from Stanford University and a B.S. in chemistry from Georgetown University.
• ·No arrangements or understandings led to Mr. Wehner's appointment; no family relationships with other directors or officers.
• ·Company to enter standard indemnification agreement with Mr. Wehner.

27-02-2026

Disc Medicine, Inc. approved a restructuring plan on February 26, 2026, to reduce its workforce by approximately 20%, primarily in commercial and supporting functions, following an FDA complete response letter on February 13, 2026, for its bitopertin New Drug Application. The company expects $2.0 million in aggregate charges, mainly severance, to be recorded primarily in Q1 2026, with implementation completing in Q2 2026. This move aligns the workforce with near-term priorities amid the regulatory setback.

• ·Restructuring primarily affects commercial functions and certain supporting functions.
• ·FDA complete response letter dated February 13, 2026, for bitopertin NDA treating erythropoietic protoporphyria and X-linked protoporphyria.
• ·Actual costs may differ from estimates due to assumptions and potential additional expenses.

27-02-2026

Invitation Homes' March 2026 investor presentation highlights a fortress balance sheet with $1.7B liquidity, 5.3x net debt to TTM adjusted EBITDA, and no debt maturities before June 2027, alongside the accretive acquisition of ResiBuilt expected to contribute $0.02 per share to 2026 AFFO and superior same-store NOI growth of +64.3% since 2017 versus peers. Same-store blended rental rate growth for Jan-Feb 2026 slowed to 1.5% from 1.8% in 4Q 2025, driven by new lease declines of -3.4% despite outpacing multifamily peers and maintaining 96.0% average occupancy. The presentation underscores structural demand for single-family rentals, with ~93% of SFR homes owned by small operators and an implied valuation of ~$270k per home at ≥7% cap rate.

• ·No debt maturities before June 2027; secured debt / gross RE assets at 6.1% (<10% target)
• ·JV & 3PM platform manages 24,000 homes with $87M FY2025 revenue and ~$0.01 accretion per 3,000 homes added
• ·95.9% same-store average occupancy rate and 79% average renewal rate as of 12/31/2025
• ·>39 months same-store average resident tenure; 4.09/5.0 cumulative Google/Yelp rating
• ·Atlanta represents 13% of 4Q25 revenue; primary focus on infill locations in high-growth markets

27-02-2026

On February 25, 2026, affiliates of Amberjack Capital Partners, L.P. (Selling Stockholders) entered into an Underwriting Agreement with J.P. Morgan Securities LLC and others to sell 5,750,000 shares of Innovex International, Inc. (INVX) common stock at $25.75 per share, with the full 30-day option for 862,500 additional shares exercised, totaling 6,612,500 shares sold. The Company repurchased 575,000 of these shares from the Underwriters for approximately $14.1 million under its existing share repurchase program, leaving $76.6 million remaining in authorization; the Company received no proceeds from the stockholder sale.

• ·Underwriting Agreement dated February 25, 2026; Offering closed February 27, 2026
• ·Pursuant to effective S-3 shelf registration (File No. 333-282178, effective October 1, 2024)
• ·Share Repurchase approved by independent committee of the Board

27-02-2026

On February 27, 2026, Robert M. Williams, Jr. resigned as a Class I director of Aveanna Healthcare Holdings Inc. (AVAH), effective immediately, with no disagreement on the company's operations, policies, or practices. Prior to his resignation, Mr. Williams served on the Nominating and Corporate Governance Committee, the Compensation Committee, and the Clinical Quality and Compliance Committee. The filing was signed by Jeff Shaner, Chief Executive Officer.

• ·Company headquartered at 400 Interstate North Parkway SE, Atlanta, Georgia 30339.
• ·Registrant is a Delaware corporation with IRS Employer Identification No. 81-4717209 and Commission File Number 001-40362.

27-02-2026

Aardvark Therapeutics voluntarily paused its Phase 3 HERO trial (NCT06828861) and open-label extension (NCT07197034) evaluating ARD-101 for hyperphagia in Prader-Willi Syndrome due to reversible cardiac observations at above-target therapeutic doses in a healthy volunteer study. The company is conducting a comprehensive data review out of caution, halting enrollment and dosing, and no longer anticipates topline data in Q3 2026, planning further guidance in Q2 2026. While prioritizing patient safety and committing to advance the ARD-101 program with optimal dosing, this pause represents a significant delay in the clinical timeline.

• ·ARD-101 granted FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Prader-Willi Syndrome (PWS).
• ·Aardvark developing ARD-201 as fixed-dose combination of ARD-101 with DPP-4 inhibitor in two Phase 2 trials.
• ·Risk factors detailed in 10-Q for quarter ended September 30, 2025, filed November 13, 2025.

27-02-2026

Hashdex Nasdaq Crypto Index US ETF filed an 8-K disclosing Amendment #1 to its Authorized Participant Agreement with Virtu Americas LLC and sponsor Hashdex Asset Management Ltd., dated February 24, 2026. The amendment replaces the Procedures Handbook in full, updates the agreement summary, adds Section 16 for optional in-kind transactions using digital assets for Creation Unit creations/redemptions (minimum 10,000 Shares), and addresses regulatory changes, fees, taxes, and settlement procedures. No financial impacts or performance metrics are disclosed.

• ·Original Authorized Participant Agreement dated January 14, 2025.
• ·SEC Registration Statement No.: 333-280990.
• ·Purchase Order cut-off time: 3:00 P.M. Eastern.
• ·Standard settlement: T+1 business day following purchase order date.

27-02-2026

VERAXA Biotech AG shareholders approved the merger with Veraxa Biotech Holding AG and an ordinary capital increase of up to CHF 223,400 at their EGM on February 27, 2026, advancing the business combination with Voyager Acquisition Corp. (NASDAQ: VACH). The approvals are prerequisites for closing, subject to Voyager shareholder approval, after which the combined entity will trade on NASDAQ under 'VRXA'. No financial performance metrics or declines were reported, highlighting progress without disclosed setbacks.

• ·Business Combination Agreement signed on April 22, 2025.
• ·Proxy statement/prospectus filed with SEC on February 19, 2026.
• ·Merger via absorption: Veraxa Biotech Holding AG acquires VERAXA and renames to Veraxa Biotech AG.

27-02-2026

Energy Vault Holdings, Inc. issued an additional $10M in 5.250% Convertible Senior Notes due 2031 (Option Notes) to initial purchasers Jefferies LLC, Cantor Fitzgerald & Co., and Citigroup Global Markets Inc., bringing the total notes outstanding to $150M following the initial $140M issuance on February 17, 2026. The company entered into additional capped call transactions to reduce potential dilution upon conversion, with a cap price of $8.12 per share (100% premium over the February 11, 2026 closing price of $4.06). Proceeds from the initial notes were used to repay $45M in senior unsecured convertible debentures to YA II PN, Ltd. on February 19, 2026.

• ·Notes sold in transaction exempt from Securities Act registration requirements
• ·Additional Capped Call Transactions cover shares initially underlying the Option Notes, subject to customary adjustments
• ·Company does not intend to file registration statement for resale of Notes or shares issuable upon conversion
• ·Purchase Agreement dated February 11, 2026

27-02-2026

Intuitive Machines, Inc. entered into a Registration Rights Agreement dated February 27, 2026, with investors party to a Securities Purchase Agreement dated February 25, 2026, providing for the registration of resale of Registrable Securities (shares issued thereunder). The Company is required to file a Registration Statement with the SEC no later than April 1, 2026, and use commercially reasonable efforts to have it effective within 30-60 days, maintaining effectiveness for up to five years from the Closing Date, subject to limited suspension periods. No financial metrics or performance data are disclosed in the agreement.

• ·Effectiveness targets: 30 days post-filing if no SEC review, 60 days if reviewed
• ·Allowed Delays: up to 45 consecutive days or 60 total calendar days in any one-year period, not more than two per year
• ·Effectiveness Period: until no Registrable Securities remain or fifth anniversary of Closing Date

27-02-2026

Mechanics Bancorp announced the adoption of Amended and Restated Bylaws effective February 25, 2026, via an 8-K filing on February 27, 2026, covering Items 5.03, 8.01, and 9.01. The bylaws detail governance procedures for shareholder meetings (annual and special, with special meetings callable by the Board, Chair, President, Secretary, or shareholders holding at least 10% of voting shares), board of directors, officers, shares, indemnification, and forum selection. No financial metrics, changes, or impacts are disclosed.

• ·Special meeting requests require a proper form initial request for Requested Record Date, followed by requests from shareholders holding the Requisite Percentage (10%) within 60 days.
• ·Business at special meetings limited to Proposed Business in valid requests, notice, or Board/chair direction.
• ·Detailed shareholder notice requirements under Section 1.12, including questionnaires, representations, and director nominee eligibility.

27-02-2026

Paramount Skydance Corporation (PSKY) will acquire Warner Bros. Discovery, Inc. (WBD) for $31.00 per share in cash, valuing WBD at $81B equity value and $110B enterprise value (7.5x fully synergized 2026 EBITDA), with over $6B in expected synergies from technology, efficiencies, and operations. The deal, unanimously approved by both boards, is funded by $47B in new Class B shares at $16.02/share from the Ellison Family and RedBird Capital Partners, plus $54B debt commitments, and is expected to close in Q3 2026 subject to regulatory and shareholder approvals. Strategic benefits include a combined film library of over 15,000 titles, commitment to 30 theatrical films annually, and enhanced DTC platforms like Paramount+, HBO Max, and Pluto.

• ·Shareholder vote expected in early spring 2026
• ·Conference call and webcast on March 2, 2026 at 8:30am ET
• ·Transaction terminates Paramount's prior all-cash tender offer for WBD
• ·Financial advisors: Centerview Partners LLC, RedBird Advisors (Paramount lead); Allen & Company, J.P. Morgan, Evercore (WBD)

27-02-2026

VisionWave Holdings, Inc. entered into a letter agreement dated February 26, 2026, with YA II PN, Ltd. to issue a $20M promissory note (net of 15% discount) and a warrant for 1,333,333 common shares exercisable for 5 years, under the existing SEPA with $49M remaining commitment after a prior $5M prepaid advance. The funding comes with strict covenants prohibiting related party payments, new indebtedness beyond permitted limits ($250k), variable rate transactions, and liens, while requiring subsidiary guaranties and future registration of warrant shares within 90 days of closing. This provides liquidity but introduces dilution risk and operational restrictions.

• ·SEPA originally dated July 25, 2025, amended January 19, 2025.
• ·Registration Statement for 10.2M SEPA shares declared effective February 17, 2026; no amendment required for new note or warrant shares.
• ·Warrant Registration Statement due within 90 days after Closing Date; demand registration within 45 days of notice.
• ·Prohibitions include prepayments to Evie Autonomous LTD and deferred underwriting commissions from Bannix Acquisition Corp. IPO.

27-02-2026

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI), a clinical-stage biopharmaceutical company, announced an investor conference call on March 4, 2026, at 6:00 a.m. PT / 9:00 a.m. ET to present initial Phase 1 dose-escalation results from the NEO212-01 trial evaluating an oral bioconjugated temozolomide platform for CNS malignancies. The call will cover safety, toxicity, pharmacokinetics, and regulatory next steps, featuring management and Scientific Advisory Board members. No specific data or outcomes were disclosed in this announcement.

• ·Patent protections for NEO™ platform extending to 2038.
• ·NEO100™ and NEO212™ advancing in Phase II trials under FDA Fast-Track and IND status.
• ·Exclusive worldwide license from University of Southern California for NEO100, NEO212, and related patents.
• ·Live webcast accessible at https://www.webcaster5.com/Webcast/Page/3151/53708 or https://investors.neonc.com.

27-02-2026

On February 24, 2026, NextNav Inc.'s Board of Directors increased its size from 9 to 10 members and appointed Lisa Hook as a new director to fill the vacancy, naming her Lead Independent Director and a member of the Technology and National Defense Committee and Compensation and Human Capital Committees. Ms. Hook's compensation includes an initial equity grant of approximately $75,000, an annual equity grant of approximately $175,000, and an annual cash retainer of $80,000, plus standard committee fees. Her term expires at the 2026 Annual Meeting of Stockholders, where she will stand for reelection, and the Company will enter into a standard indemnity agreement with her.

• ·No arrangements or understandings exist between Ms. Hook and any other person regarding her appointment.
• ·No transactions requiring disclosure under Item 404(a) of Regulation S-K involving Ms. Hook.
• ·Indemnity agreement with Ms. Hook to be substantially the same as for other directors (filed as Exhibit 10.2 to 8-K on October 28, 2021).

27-02-2026

Eastman Kodak Company entered into a new Executive Chairman and CEO Agreement with James V. Continenza, effective January 1, 2026, extending his employment term until December 31, 2030, replacing his prior agreement set to expire February 26, 2027. The agreement includes an annual base salary of $1.2M, annual cash incentive up to 125% of base salary ($1.5M max), a one-time renewal award of 5M RSUs vesting equally over five years starting December 31, 2026, and annual RSU awards valued at $2.5M (half time-vesting over three years, half performance-vesting). Termination provisions provide for two years' salary and incentive, accelerated vesting of certain RSUs, and 18 months of COBRA coverage if terminated without cause or for good reason.

• ·Mr. Continenza must provide 61 days' written notice before exercising certain stock options (February 2019 or July 2020 grants) if post-exercise ownership would exceed 4.99%.
• ·Full Employment Agreement to be filed as exhibit to Form 10-K for year ended December 31, 2025.

27-02-2026

IP Strategy Holdings, Inc. (IPST) reported preliminary Q4 2025 net revenues of $4.6-4.8M, up ~53-60% QoQ from $3.0M in Q3, and full-year 2025 revenues of $9.8-10.3M, up ~17-23% YoY from $8.4M in 2024, driven by validator operations at >95% gross margins. However, Q4 net loss before taxes swung to $380-384M from Q3 profit of $245.7M, and full-year loss reached $146.5-148.5M from 2024 profit of $0.7M, primarily due to $126.5-129.5M mark-to-market loss on 53.2M $IP Tokens amid a price drop from $8.54 to $1.732. Restructuring closed retail tasting rooms with $3.2-3.6M write-downs but eliminated $19.3M debt (saving >$2M annual interest) and >$5M annual op ex from 2026, net of ~$3.5M revenue loss.

• ·$IP Tokens acquired at average basis of $3.93 per token
• ·Q4 2025 third-party staking fees: 40,595 $IP Tokens
• ·Annual interest expense savings >$2M; op ex savings >$5M from 2026 (net of ~$3.5M revenue loss)

27-02-2026

On February 24, 2026, Ambarella Inc.'s Compensation Committee approved the Fiscal Year 2027 Annual Bonus Plan (FY2027 Bonus Plan), featuring an aggregate target bonus pool approximately 28% larger than the FY2026 plan. CEO Feng-Ming Wang is eligible for a 100% bonus target of his base salary, with other executives (John Young, Chan Lee, John Ju, Yun-Lung Chen) ranging from 40% to 75%; payouts are weighted 1/3 each on revenue, operating profit, and non-financial objectives, with a maximum of 167% of target. No threshold performance results in zero funding, and payouts require continued employment.

• ·Compensation Committee and Board have discretion to adjust bonus pool size and individual payouts.
• ·Payouts to be made no later than two and one-half months after end of FY2027.
• ·Performance between threshold and target uses linear interpolation.

27-02-2026

Landmark Bancorp, Inc. selected Forvis Mazars, LLP as its new independent registered public accounting firm for the fiscal year ending December 31, 2026, following a competitive process by the Audit Committee, with Crowe LLP dismissed effective after completing the 2025 audits. There were no disagreements or reportable events with Crowe during fiscal years 2024 and 2025, and Crowe's audit reports were unqualified. Crowe provided a letter dated February 27, 2026, concurring with the disclosures.

• ·Crowe’s audit reports on consolidated financial statements for fiscal years ended December 31, 2024 and 2025 did not contain adverse opinions, disclaimers, or qualifications as to uncertainty, audit scope, or accounting principles.
• ·No prior consultations with Forvis Mazars on accounting principles, audit opinions, or related matters before retention.
• ·Forvis Mazars engagement begins with review of Q1 2026 quarterly consolidated financial statements, subject to client acceptance procedures.

27-02-2026

Flagstar Bank, N.A. (NYSE: FLG) announced its 2026 Annual Meeting of Shareholders on June 9, 2026, at 10:00 a.m. ET in a virtual format, with a record date of April 10, 2026; proxy materials will be filed with the OCC and SEC. As of December 31, 2025, the Bank reported $87.5B in assets, $61.0B in loans, $66.0B in deposits, and $8.1B in stockholders' equity, while operating approximately 340 locations across ten states. The release includes cautionary forward-looking statements referencing prior events like the October 2025 reorganization and no new performance metrics.

• ·Bank headquartered at 102 Duffy Avenue, Hicksville, NY 11801.
• ·Operates with strong footholds in greater New York/New Jersey, upper Midwest, Florida, and West Coast.

27-02-2026

On February 27, 2026, Bridgewater Bancshares, Inc. and its subsidiary Bridgewater Bank entered into an Equity Distribution Agreement with Piper Sandler & Co. to issue and sell up to $50 million of common stock through at-the-market offerings. The agreement allows sales via various methods, with the company paying a 2.5% commission on gross sales prices; there is no obligation to sell any shares, and either party may terminate at any time. Net proceeds, if any, will support general corporate purposes such as subsidiary investments, working capital, capital expenditures, stock repurchases, debt repayment, or acquisitions.

• ·Sales under the agreement will be made pursuant to shelf registration statement Form S-3 (No. 333-284662), effective February 10, 2025, with prospectus supplement filed February 27, 2026.
• ·Agreement includes customary representations, warranties, covenants, indemnification, and expense reimbursements.

27-02-2026

OpGen, Inc. (OTC: OPGN) announced its name change to CapForce Inc., effective February 27, 2026, to reflect a repositioning toward digital investment banking and fintech services targeting high-growth mid-sized companies with $1B-$10B market caps. The company plans to change its ticker to 'CFOR' and is developing a digital platform with AI-powered robo-advisory and cap table management, subject to market and regulatory factors; its controlling shareholder AEI Capital Group manages over $7B in AUM. Forward-looking statements highlight risks including rebranding costs, execution challenges, and potential customer/investor confusion.

• ·Name change effective February 27, 2026
• ·Expected ticker symbol change to 'CFOR'
• ·Subsidiaries: CapForce International Holdings Ltd. and iCapX Sdn. Bhd.
• ·AEI Capital Group footprints: Hong Kong, Kuala Lumpur, Singapore, London, Washington D.C.